LegiPlex
Legislation Monitoring
& Workspaces
US
Federal
& States
About
Sign Up
Login
...
US
US Federal US
Legislatures
2025-2026 Regular Session
House
Bills
HB5316
US
US Federal House Bill HB5316
US Federal 2025-2026 Regular Session
Overview
Activity Timeline
Videos
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Menu
US
US Federal 2025-2026 Regular Session
US Federal House Bill HB5316
Introduced
9/11/25
Refer
9/11/25
Caption
Drug Shortage Compounding Patient Access Act of 2025
Companion Bills
No companion bills found.
Previously Filed As
US SB0282
Compounding drugs; registration of medical spas.
US SB2665
Drug Shortage Prevention Act of 2025
US HB6117
Patient Device Data Access Act of 2025
US SB652
Protecting Patients from Deceptive Drug Ads Act
US H1407
Compounding Pharmacies
US HB6509
SAFE Drugs Act of 2025 Safeguarding Americans from Fraudulent and Experimental Drugs Act of 2025
US SB3794
SAFE Drugs Act of 2026 Safeguarding Americans from Fraudulent and Experimental Drugs Act of 2026
US HB4441
Patient Access to Innovative New Technologies Act of 2025
US HF3832
Definition of compounding of a drug amended to exempt the use of a flavoring agent.
US SF3783
Compounding of a drug definition modification to exempt the use of a flavoring agent
Similar Bills
CA AB2442
Peptides.
HI HB2164
Relating To Workers' Compensation.
HI SB2751
Relating To Workers' Compensation.
CO SB066
Regulation of Compounded Weight-Loss Medication
CA AB1990
Pharmacy Law: compounded medications: consumer protection.
LA SB253
Provides relative to peptides. (8/1/26)
IN SB0282
Compounding drugs; registration of medical spas.
TX HB3785
Relating to labeling requirements for compounded drug products.